TSX News -
Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform
SAINT LAURENT, Quebec, Feb. 05, 2024 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced positive results [...]